Clinical Trial Government Bids & RFPs

The period of performance for this contract is from April 15, 2026, through April 14, 2028.

The bid notice states that capability statements must include convincing evidence that clearly demonstrates the capability to provide the warranties.

This is a notice of intent to award a sole source contract, indicating that the award will be made to a single responsible source.

Sources interested in responding are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the warranties and proof as being capable of providing the requesting services.

Capability statements are due by 10:00 AM Eastern Standard Time EST, April 8, 2026.

The bid notice states that the award will be made on a firm fixed price sole source award basis. he national institutes of health nih intends to award a fixed price purchase order to global life sciences solutions, on a firm fixed price sole source award basis to provide software upgrades to the national institutes of health.

The bid notice states that FDA mandates all repairs and maintenance be carried out by qualified technicians, and Cytiva Global Life Sciences Solutions USA LLC is the only source of qualified technicians. he fda mandates that all repairs and maintenance are carried out by qualified technicians. cytiva global life sciences solutions usa llc is the only source of technicians qualified to service these devices and upgrade their software.

The bid notice states that comments may be submitted prior to the closing date specified in the announcement. comments to this announcement, referencing this posting number, may be submitted to the nih, clinical center, office of purchasing and contracts, prior to the closing date specified in this announcement, to the attention of kristin nagashima, contract specialist via email to ***@***. *. * by march 26, 2026 at 11am est.

The estimated period of performance for the clinical evaluation services is from April 2026 to October 2027.

The contractor shall submit a manually created invoice to the TPOC cited above. The TPOC will then review, prepare and submit the invoice package and send it to the payment office identified in block 18a. Vendor invoice shall include the following information for proper invoice: invoice number, invoice date, contract line item number, service/material receipt date, service/material acceptance date.

This is a notice of intent to award a sole source contract. Any responsible source that believes it is capable of meeting the requirement may submit a capability statement for consideration.

The justification for sole source states that KATH is the only source capable of providing the required services due to unique access to patient populations, existing regulatory approvals, specialized facilities and personnel, and compliance and established trust.

The work involves the clinical evaluation of the Xpert Tropical Fever Test on the Genexpert Edge X system using venous and capillary whole blood specimens.

All capability statements received no later than April 2, 2026, 2:00 PM Central European Time CET will be considered by the government.

The estimated value of the contract is 199,****.